Delbari A, Naderyan Feli S, Amirabadizadeh A, Niroomand M, Bidkhori M
PLoS One. 2024; 19(10):e0306388.
PMID: 39441866
PMC: 11498658.
DOI: 10.1371/journal.pone.0306388.
Shafiee A, Kazemian S, Jalali A, Alaeddini F, Saadat S, Masoudkabir F
Arch Iran Med. 2024; 27(2):51-61.
PMID: 38619028
PMC: 11017263.
DOI: 10.34172/aim.2024.10.
Razzaghpour N, Najafi A, Sabouri M, Ashoori N, Shahraki K
Med Hypothesis Discov Innov Ophthalmol. 2024; 12(3):150-156.
PMID: 38476576
PMC: 10926313.
DOI: 10.51329/mehdiophthal1480.
Farjam M, Kheirandish M, Ghanbarnejad A, Nikpoor A, Nejatizadeh A, Aghamolaei T
Arch Iran Med. 2024; 27(1):15-22.
PMID: 38431956
PMC: 10915932.
DOI: 10.34172/aim.2024.03.
Rezaianzadeh A, Niazkar H, Rezaeianzadeh R, Jafari F, Rahimikazerooni S, Ghoddusi Johari M
BMJ Open. 2024; 14(2):e077116.
PMID: 38331866
PMC: 10860034.
DOI: 10.1136/bmjopen-2023-077116.
Dietary acid load and its interaction with CETP TaqB1 polymorphisms on lipid profile among patients with Type 2 diabetes mellitus.
Abaj F, Esmaeily Z, Naeini Z, Alvandi E, Rafiee M, Koohdani F
BMC Endocr Disord. 2023; 23(1):138.
PMID: 37407953
PMC: 10320954.
DOI: 10.1186/s12902-023-01391-6.
The relationship of reproductive factors with adiposity and body shape indices changes overtime: findings from a community-based study.
Amiri M, Mousavi M, Azizi F, Ramezani Tehrani F
J Transl Med. 2023; 21(1):137.
PMID: 36814308
PMC: 9948339.
DOI: 10.1186/s12967-023-04000-1.
Atherogenic dyslipidemia and associated risk factors among hypertensive patients of five health facilities in Northeast Ethiopia.
Mohammed O, Alemayehu E, Ebrahim E, Fiseha M, Gedefie A, Ali A
PLoS One. 2023; 18(2):e0277185.
PMID: 36787318
PMC: 9928121.
DOI: 10.1371/journal.pone.0277185.
Level and trend of total plasma cholesterol in national and subnational of Iran: a systematic review and age-spatio-temporal analysis from 1990 to 2016.
Mehdipour P, Mohammadi E, Sepanlou S, Ahmadvand A, Peykari N, Djalalinia S
J Diabetes Metab Disord. 2022; 21(2):1301-1315.
PMID: 35668771
PMC: 9150051.
DOI: 10.1007/s40200-022-01052-w.
Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies.
Mohammadian Khonsari N, Shahrestanaki E, Ejtahed H, Djalalinia S, Sheidaei A, Hakak-Zargar B
Curr Hypertens Rep. 2021; 23(9):41.
PMID: 34625888
DOI: 10.1007/s11906-021-01159-0.
Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey.
Nikparvar M, Khaladeh M, Yousefi H, Farashah M, Moayedi B, Kheirandish M
Sci Rep. 2021; 11(1):9125.
PMID: 33911149
PMC: 8080669.
DOI: 10.1038/s41598-021-88680-z.
Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia.
Gebreegziabiher G, Belachew T, Mehari K, Tamiru D
PLoS One. 2021; 16(2):e0243103.
PMID: 33561153
PMC: 7872241.
DOI: 10.1371/journal.pone.0243103.
Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia.
Alzaheb R, Altemani A
Diabetes Metab Syndr Obes. 2020; 13:4033-4040.
PMID: 33149642
PMC: 7604430.
DOI: 10.2147/DMSO.S246068.
Changes in plasma lipid and in-hospital deaths in patients with sepsis.
Nabavi A, Allami A, QasemiBarqi R
Med J Islam Repub Iran. 2020; 34:45.
PMID: 32884920
PMC: 7456431.
DOI: 10.34171/mjiri.34.45.
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study.
Rezaei M, Fakhri N, Pasdar Y, Moradinazar M, Najafi F
Lipids Health Dis. 2020; 19(1):176.
PMID: 32723339
PMC: 7388539.
DOI: 10.1186/s12944-020-01354-z.
Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran.
Moradinazar M, Pasdar Y, Najafi F, Shahsavari S, Shakiba E, Hamzeh B
BMC Public Health. 2020; 20(1):673.
PMID: 32404075
PMC: 7218585.
DOI: 10.1186/s12889-020-08809-z.
Contributions and Implications of the Tehran Lipid and Glucose Study.
Azizi F, Takyar M, Zadeh-Vakili A
Int J Endocrinol Metab. 2018; 16(4 Suppl):e84792.
PMID: 30584448
PMC: 6289319.
DOI: 10.5812/ijem.84792.
Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study.
Azizi F, Zadeh-Vakili A, Takyar M
Int J Endocrinol Metab. 2018; 16(4 Suppl):e84777.
PMID: 30584442
PMC: 6289309.
DOI: 10.5812/ijem.84777.
Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases.
Baghbani-Oskouei A, Tohidi M, Asgari S, Ramezankhani A, Azizi F, Hadaegh F
Int J Endocrinol Metab. 2018; 16(4 Suppl):e84750.
PMID: 30584435
PMC: 6289304.
DOI: 10.5812/ijem.84750.
Prevalence of Hypercholesterolemia, High LDL, and Low HDL in Iran: A Systematic Review and Meta-Analysis.
Akbartabar Toori PhD M, Kiani MSc F, Sayehmiri PhD F, Sayehmiri PhD K, Mohsenzadeh MD Y, Ostovar PhD R
Iran J Med Sci. 2018; 43(5):449-465.
PMID: 30214097
PMC: 6123550.